A 58-year-old man presented to the emergency department (ED) several hours after taking a mixed overdose of his antihypertensive medications with alcohol. From the packaging found at scene it was estimated that he had taken 500 mg ramipril, 500 mg amlodipine and 82 mg doxazosin. On admission to the ED he was conscious but intoxicated with a best Glasgow Coma Score (GCS) of 14 and a blood pressure of 53/30 mm Hg. He was resuscitated with fluid and started on a metaraminol infusion while an arterial line was inserted. He initially responded to treatment but subsequently deteriorated to a minimum intra-arterial blood pressure of 43/28 mm Hg despite increasing the metaraminol infusion to 30 mg metaraminol/hr. A central venous catheter was inserted and noradrenaline infusion was started and increased to 8 mg/hr within an hour. Calcium gluconate 10 mL of 10% was given and vasopressin was added and titrated up to 4 units/hr.
After consultation with the poisons unit in Birmingham it was decided to use high dose insulin therapy. This involved loading the patient with 50% dextrose and commencing therapy with a bolus of 1 unit/kg (80 units) of actrapid. This was followed by a background infusion of 10% dextrose together with an insulin infusion starting at 0.5 units/kg/hr (40 units) which was increased every hour to 2 units/kg/hr (160 units/hr) according to effect. The maximum rate for insulin infusion is 10 units/kg/hr (800 units). However, this did not appear to improve the cardiovascular situation and resulted in the need for a high rate central venous infusion of potassium in order to maintain potassium levels.
The patient remained hypotensive at 80/35 mm Hg and was profoundly acidotic with a pH of 7.21, base excess of -13.2 mmoL/L, and lactate of 8.3 mmoL/L. His GCS dropped to 11 (E 2 V 4 M 5 ) and he started to vomit so he was intubated and mechanically ventilated. In view of the hypotension, ketamine was chosen as the induction agent. An initial dose of 100 mg was given and the patient appeared sedated. This was followed by 100 mg of suxamethonium and, although sedated, the patient did not stop breathing or fasciculate. It was noted that his blood pressure had increased to more than 100 mm Hg systolic.
Inspection of the IV site revealed that it had 'tissued', presumably after some of the ketamine had been administered but before the suxamethonium had been given. The patient continued to breathe 100% oxygen while further doses of ketamine and suxamethonium were administered via alternative venous access. Tracheal intubation was successfully performed and the increase in blood pressure was sustained.
In view of the cardiovascular response we elected to start a ketamine infusion at 500 mg/hr for sedation and to stop the high dose insulin therapy. This allowed us to significantly reduce the vasopressin infusion over the next few hours (Figure 1 ). The patient' s urine output improved with the increased blood pressure but he remained acidotic so we initiated haemofiltration and the acidosis improved.
The patient remained on the ketamine infusion for 38 hours. Figure 1 shows continuing improvement in blood pressure with reducing doses of insulin and vasopressin and a steady dose of noradrenaline. The ketamine produced a small but sustained increase in blood pressure to a level where organ perfusion was adequate. It altered the situation from one where we were rapidly increasing the noradrenaline, vasopressin and insulin to one where we could stop the insulin and reduce the vasopressin. The high dose insulin therapy appeared to us to be the most dangerous therapy that we were giving and the high requirement for potassium continued for many hours after the insulin was stopped. The patient was discharged from hospital 10 days after admission following which he continued to receive care from the mental health team.
Discussion
Amlodipine is a competitive calcium channel antagonist of the dihydropyridine group which demonstrates gradual association and dissociation with the receptor binding site. 1 It is used to treat hypertension, angina and heart failure by causing peripheral vasodilatation and reducing afterload. It acts primarily on voltage-gated (L-type) calcium channels and in overdose can have more effects on the heart by reducing contractility and slowing atrio-ventricular conduction. 2 Peak plasma concentrations occur between 6 and 12 hours after ingestion and it has an elimination half-life of 35-50 hours. 3 Doxazosin is an α-1 selective alpha adrenergic reversible non-competitive antagonist 4 which is used to treat resistant hypertension by inhibiting the binding of noradrenaline. It is a potent vasodilator and can cause postural hypotension in patients. 2 Peak plasma concentrations occur 2-3 hours after dosing with an elimination half-life of 22 hours. 5 Ramipril is an angiotensin converting enzyme (ACE) inhibitor antagonising the conversion of inactive angiotensin I into active angiotensin II and thus reducing sodium and water retention, vasomotor tone, preload, afterload and myocardial work. It is used in the treatment of hypertension, heart failure
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Metaraminol and noradrenaline act via the α-1 adrenoceptor which is blocked by doxazosin. Vasopressin causes vasoconstriction in supra-physiological doses by acting on the V 1a receptors in the heart and smooth muscle which cause an increase in intracellular calcium via the phosphatidyl-inositolbisphosphonate cascade. 7 However there are many studies linking the dihydropyridine receptor with calcium-induced calcium release 8, 9 which is an important positive feedback mechanism in skeletal and smooth muscle. This is the receptor blocked by amlodipine which explains why the vasopressin was ineffective.
High dose insulin therapy is recommended for the treatment of β-blocker and calcium channel antagonist overdoses. 10 It is thought to mediate its effect through multiple different mechanisms of action. It vasodilates coronary, pulmonary and systemic vasculature and enhances microvascular perfusion via endothelial nitric oxide synthase activity. 11 It has inotropic effects via improved glucose utilisation and metabolism, increased intracellular calcium via trans-sarcolemmal influx and PI-3-kinase-dependent, reverse-mode Na + /Ca 2+ exchange activation with consequent increased trans-sarcolemmal Ca 2+ entry during the early phase of the action potential. 12 The concurrent profound vasodilatation from the mixed overdose could have been exacerbated by high dose insulin therapy thus attenuating its effect.
Ketamine is a phencyclidine derivative which is a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) receptor calcium ion channel. 13 It produces a dissociative anaesthesia with profound analgesia while keeping patients cardiovascularly stable and maintaining their laryngeal reflexes. A study of ketamine infusions for elective surgery found a cardio-stimulatory action in all patients with the peak in mean arterial pressure 10 min after starting and not returning to baseline in the non-paralysed cohort. 14 The effect it has on voltage sensitive Ca 2+ channels (VSCC) is not fully understood but it is thought that it antagonises VSCC in airway smooth muscle causing a significant reduction in peak Ca 2+ current and therefore bronchodilatation. 15, 16 It has also been reported to cause a 20% reduction in the peak current in guinea pig myocardium by inhibiting calcium entry to the cell. 17 However it has been shown that pre-treatment with nimodipine, a calcium channel antagonist, attenuates the behavioural effects of ketamine. 18 Although it is not clear what are the exact effects of ketamine on calcium channels, most research suggests a non-competitive inhibition which would accentuate the negative inotropic effects of the overdose, not improve it. Ketamine is known to stimulate the sympathetic nervous system and release endogenous adrenaline and noradrenaline which accounts for its cardiovascularly stability on induction compared with other induction agents. 19 However the effect of endogenous catecholamines on top of the 8 mg/hr exogenous noradrenaline where the doxazosin is acting as a direct antagonist would likely be negligible. The contractile response of rabbit aorta to adrenaline and noradrenaline were potentiated in a dose-related manner by S(+) ketamine 20 
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possibly by inhibition of extraneuronal uptake of catecholamines. The β1 effects of adrenaline cause increased contractility and automaticity which is augmented by the ketamine and may explain the improvement we saw in blood pressure. Adrenaline also increases renin release but this will be prevented from being converted into its active form by the ramipril. 21 There are two case reports where the inotropic requirements of a severely septic patient were reduced when ketamine was used for sedation. In the report by Park et al the patient was on dobutamine which they were able to stop after a sustained increase in systolic blood pressure of approximately 20 mm Hg. 22 Yli-Hankala et al reported a patient who was on dobutamine, dopamine and noradrenaline; the dobutamine was stopped after an induction bolus of ketamine and the dopamine and noradrenaline were reduced by 33.3% and 37.1% respectively, while achieving a MAP 50 mm Hg above baseline. 23 This would reinforce the suggestion that ketamine augments the β1 effects of adrenaline to a clinically significant level.
Conclusion
The combination of drugs in this overdose created a situation where there was resistance to conventional treatments. It was 72 hours before the patient was haemodynamically stable enough to extubate, which is 1.5 times the elimination half-life of the longest acting drug. Multiple vasopressors were used following Toxbase ® guidelines, 3 however ketamine produced the most significant increase in blood pressure. Ketamine is not part of the recognised guidelines for antihypertensive overdose but, while we do not know the mechanism of action for certain, without it the outcome may have been less satisfactory. The guidelines are written for overdoses in individual agents but sometimes the whole is greater than the sum of its parts and therefore conventional therapy fails. We suggest that a ketamine infusion should be considered as an adjunct when conventional vasopressor therapy fails, especially in a complex mixed overdose.
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